C. A. Matos, S. De-macedo-ribeiro, and A. L. Carvalho, Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease, Prog. Neurobiol, vol.95, pp.26-48, 2011.

S. W. Davies, M. Turmaine, B. A. Cozens, M. Difiglia, A. H. Sharp et al., Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation, Cell, vol.90, pp.537-548, 1997.

A. Lunkes and J. L. Mandel, Polyglutamines, nuclear inclusions and neurodegeneration, Nat. Med, vol.3, pp.1201-1202, 1997.

M. Koike, J. Fukushi, Y. Ichinohe, N. Higashimae, M. Fujishiro et al., Valosin-containing protein (VCP) in novel feedback machinery between abnormal protein accumulation and transcriptional suppression, J. Biol. Chem, vol.285, pp.21736-21749, 2010.

J. Legleiter, E. Mitchell, G. P. Lotz, E. Sapp, C. Ng et al., Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo, J. Biol. Chem, vol.285, pp.14777-14790, 2010.

M. Li, E. S. Chevalier-larsen, D. E. Merry, and M. I. Diamond, Soluble androgen receptor oligomers underlie pathology in a mouse model of spinobulbar muscular atrophy, J. Biol. Chem, vol.282, pp.3157-3164, 2007.

M. A. Olshina, L. M. Angley, Y. M. Ramdzan, J. Tang, M. F. Bailey et al., Tracking mutant huntingtin aggregation kinetics in cells reveals three major populations that include an invariant oligomer pool, J. Biol. Chem, vol.285, pp.21807-21816, 2010.

S. L. Wong, W. M. Chan, and H. Y. Chan, Sodium dodecyl sulfate-insoluble oligomers are involved in polyglutamine degeneration, FASEB J, vol.22, pp.3348-3357, 2008.

T. Takahashi, S. Katada, and O. Onodera, Polyglutamine diseases: where does toxicity come from? what is toxicity? where are we going?, J. Mol. Cell Biol, vol.2, pp.180-191, 2010.

A. Demuro, E. Mina, R. Kayed, S. C. Milton, I. Parker et al., Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers, J. Biol. Chem, vol.280, pp.17294-17300, 2005.

T. Takahashi, S. Kikuchi, S. Katada, Y. Nagai, M. Nishizawa et al., Soluble polyglutamine oligomers formed prior to inclusion body formation are cytotoxic, Hum. Mol. Genet, vol.17, pp.345-356, 2008.

C. Behrends, C. A. Langer, R. Boteva, U. M. Bottcher, M. J. Stemp et al., Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers, Mol. Cell, vol.23, pp.887-897, 2006.

A. Wyttenbach, S. Hands, M. A. King, K. Lipkow, and A. M. Tolkovsky, Amelioration of protein misfolding disease by rapamycin: translation or autophagy?, Autophagy, vol.4, pp.542-545, 2008.

M. Latouche, C. Lasbleiz, E. Martin, V. Monnier, T. Debeir et al., A conditional pan-neuronal Drosophila model of spinocerebellar ataxia 7 with a reversible adult phenotype suitable for identifying modifier genes, J. Neurosci, vol.27, pp.2483-2492, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01930868

K. Moses and G. M. Rubin, Glass encodes a site-specific DNA-binding protein that is regulated in response to positional signals in the developing Drosophila eye, Genes Dev, vol.5, pp.583-593, 1991.

J. M. Warrick, H. Y. Chan, G. L. Gray-board, Y. Chai, H. L. Paulson et al., Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70, Nat. Genet, vol.23, pp.425-428, 1999.

J. M. Warrick, L. M. Morabito, J. Bilen, B. Gordesky-gold, L. Z. Faust et al., Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism, Mol. Cell, vol.18, pp.37-48, 2005.

D. Goti, S. M. Katzen, J. Mez, N. Kurtis, J. Kiluk et al., A mutant ataxin-3 putative-cleavage fragment in brains of Machado-Joseph disease patients and transgenic mice is cytotoxic above a critical concentration, J. Neurosci, vol.24, pp.10266-10279, 2004.

G. Yvert, K. S. Lindenberg, D. Devys, D. Helmlinger, G. B. Landwehrmeyer et al., SCA7 mouse models show selective stabilization of mutant ataxin-7 and similar cellular responses in different neuronal cell types, Hum. Mol. Genet, vol.10, pp.1679-1692, 2001.
URL : https://hal.archives-ouvertes.fr/hal-02371901

A. Haacke, S. A. Broadley, R. Boteva, N. Tzvetkov, F. U. Hartl et al., Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3, Hum. Mol. Genet, vol.15, pp.555-568, 2006.

J. Hubener, J. J. Weber, C. Richter, L. Honold, A. Weiss et al., Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type, Hum. Mol. Genet, vol.3, issue.SCA3, pp.508-518, 2013.

J. Liman, S. Deeg, A. Voigt, H. Vossfeldt, C. P. Dohm et al., Kermer, CDK5 protects from caspase-induced Ataxin-3 cleavage and neurodegeneration, J. Neurochem, vol.129, pp.1013-1023, 2014.

A. T. Simoes, N. Goncalves, A. Koeppen, N. Deglon, S. Kugler et al., Calpastatin-mediated inhibition of calpains in the mouse brain prevents mutant ataxin 3 proteolysis, nuclear localization and aggregation, relieving Machado-Joseph disease, Brain, vol.135, pp.2428-2439, 2012.

J. E. Young, L. Gouw, S. Propp, B. L. Sopher, J. Taylor et al., Proteolytic cleavage of ataxin-7 by caspase-7 modulates cellular toxicity and transcriptional dysregulation, J. Biol. Chem, vol.282, pp.30150-30160, 2007.

J. M. Warrick, H. L. Paulson, G. L. Gray-board, Q. T. Bui, K. H. Fischbeck et al., Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila, Cell, vol.93, pp.939-949, 1998.

H. P. Nguyen, J. Hubener, J. J. Weber, S. Grueninger, O. Riess et al., Cerebellar soluble mutant ataxin-3 level decreases during disease progression in Spinocerebellar Ataxia Type 3 mice, PLoS One, vol.8, p.62043, 2013.

A. Tonoki, E. Kuranaga, N. Ito, Y. Nekooki-machida, M. Tanaka et al., Aging causes distinct characteristics of polyglutamine amyloids in vivo, Genes Cells, vol.16, pp.557-564, 2011.

R. Diaz-avalos, C. Y. King, J. Wall, M. Simon, and D. L. Caspar, Strain-specific morphologies of yeast prion amyloid fibrils, Proc. Natl. Acad. Sci. U. S. A, vol.102, pp.10165-10170, 2005.

S. Hannaoui, L. Maatouk, N. Privat, E. Levavasseur, B. A. Faucheux et al., Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type, J. Virol, vol.87, pp.2535-2548, 2013.

P. Koch, P. Breuer, M. Peitz, J. Jungverdorben, J. Kesavan et al., Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease, Nature, vol.480, pp.543-546, 2011.

A. Weiss, C. Klein, B. Woodman, K. Sathasivam, M. Bibel et al., Sensitive biochemical aggregate detection reveals aggregation onset before symptom development in cellular and murine models of Huntington's disease, J. Neurochem, vol.104, pp.846-858, 2008.